Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Celecoxib in Advanced Metastatic Pancreatic Cancer
NCT00068432Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in pancreatic cancer (PC), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2003; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00068432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00068432.